IVM
InterWest Venture Management Portfolio holdings
AUM
$20.6M
This Quarter Return
+61.55%
1 Year Return
+48.5%
3 Year Return
-59.65%
5 Year Return
-75.84%
10 Year Return
–
AUM
$121M
AUM Growth
+$121M
(+27%)
Cap. Flow
-$20.4M
Cap. Flow
% of AUM
-16.88%
Top 10 Holdings %
Top 10 Hldgs %
99.96%
Holding
12
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Glaukos
GKOS
|
$14.1M |
| 2 |
MacroGenics
MGNX
|
$6.25M |
Sector Composition
| 1 | Consumer Discretionary | 54.67% |
| 2 | Healthcare | 45.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
The RealReal
REAL
$879M
| $65.9M | 54.67% | 5,154,080 | – | – |
|
|
2
Glaukos
GKOS
$5.5B
| $24.8M | 20.59% | 646,364 -367,000 | -36% | -$14.1M |
|
|
AGTC
3
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $8.07M | 6.69% | 1,455,904 | – | – |
|
|
EIGR
4
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $7.34M | 6.09% | 764,918 | – | – |
|
5
Cidara Therapeutics
CDTX
$1.66B
| $5.01M | 4.15% | 1,356,813 | – | – |
|
6
KalVista Pharmaceuticals
KALV
$678M
| $4.7M | 3.9% | 388,766 | – | – |
|
7
Venus Concept
VERO
$4.11M
| $2.3M | 1.91% | 658,657 | – | – |
|
8
Neuronetics
STIM
$220M
| $1.99M | 1.65% | 1,030,689 | – | – |
|
|
HIND
9
Vyome Holdings, Inc. Common Stock
HIND
$243M
| $268K | 0.22% | 380,224 | – | – |
|
10
Xenon Pharmaceuticals
XENE
$2.98B
| $104K | 0.09% | 8,293 | – | – |
|
11
Dare Bioscience
DARE
$27.2M
| $50K | 0.04% | 50,368 | – | – |
|
|
12
MacroGenics
MGNX
$112M
| – | – | -1,074,316 | Closed | -$6.25M |
|